Correction: Factors associated with discontinuation of biologics in patients with inflammatory arthritis in remission: data from the BIOBADASER registry
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Correction: Factors associated with discontinuation of biologics in patients with inflammatory arthritis in remission: data from the BIOBADASER registry ; volume:25 ; number:1 ; day:25 ; month:10 ; year:2023 ; pages:1 ; date:12.2023
Arthritis Research & Therapy ; 25, Heft 1 (25.10.2023), 1, 12.2023
- Creator
-
Valero, Marta
Sanchez-Piedra, Carlos
Freire, Mercedes
Colazo, Maria
Busquets, Noemi
Merino-Ibarra, Erardo
Rodriguez-Lozano, Carlos
Manrique, Sara
Campos, Cristina
Sanchez-Alonso, Fernando
Castrejon, Isabel
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13075-023-03194-5
- URN
-
urn:nbn:de:101:1-2024020809054176675746
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:30 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Valero, Marta
- Sanchez-Piedra, Carlos
- Freire, Mercedes
- Colazo, Maria
- Busquets, Noemi
- Merino-Ibarra, Erardo
- Rodriguez-Lozano, Carlos
- Manrique, Sara
- Campos, Cristina
- Sanchez-Alonso, Fernando
- Castrejon, Isabel
- SpringerLink (Online service)
Other Objects (12)
Factors associated with discontinuation of biologics in patients with inflammatory arthritis in remission: data from the BIOBADASER registry
Treatment Discontinuation in Patients with Psoriasis Treated with Biologics: A Retrospective Analysis of German Health Claims Data
Risk of Treatment Discontinuation among Patients with Psoriasis Initiated on Ustekinumab and Other Biologics in the USA
Predictors of remission in rheumatoid arthritis patients treated with biologics: a systematic review and meta-analysis
Machine learning model for identifying important clinical features for predicting remission in patients with rheumatoid arthritis treated with biologics
Evidence-Based Approach to the Discontinuation of Immunomodulators or Biologics in Inflammatory Bowel Disease
Biologics in general medicine : with 23 tables
Serious infections in patients with self-reported psoriatic arthritis from the Psoriasis Longitudinal Assessment and Registry (PSOLAR) treated with biologics
Methotrexate Discontinuation and Dose Decreases After Therapy With Tocilizumab: Results From the Corrona Rheumatoid Arthritis Registry
Factors associated with oral glucocorticoid use in patients with rheumatoid arthritis: a drug use study from a prospective national biologics registry
Drug retention of 7 biologics and tofacitinib in biologics-naïve and biologics-switched patients with rheumatoid arthritis: the ANSWER cohort study
Drug Survival, Safety, and Effectiveness of Biologics in Older Patients with Psoriasis: A Comparison with Younger Patients—A BioCAPTURE Registry Study
Factors associated with discontinuation of biologics in patients with inflammatory arthritis in remission: data from the BIOBADASER registry
Treatment Discontinuation in Patients with Psoriasis Treated with Biologics: A Retrospective Analysis of German Health Claims Data
Risk of Treatment Discontinuation among Patients with Psoriasis Initiated on Ustekinumab and Other Biologics in the USA
Predictors of remission in rheumatoid arthritis patients treated with biologics: a systematic review and meta-analysis
Machine learning model for identifying important clinical features for predicting remission in patients with rheumatoid arthritis treated with biologics
Evidence-Based Approach to the Discontinuation of Immunomodulators or Biologics in Inflammatory Bowel Disease
Biologics in general medicine : with 23 tables
Serious infections in patients with self-reported psoriatic arthritis from the Psoriasis Longitudinal Assessment and Registry (PSOLAR) treated with biologics
Methotrexate Discontinuation and Dose Decreases After Therapy With Tocilizumab: Results From the Corrona Rheumatoid Arthritis Registry
Factors associated with oral glucocorticoid use in patients with rheumatoid arthritis: a drug use study from a prospective national biologics registry
Drug retention of 7 biologics and tofacitinib in biologics-naïve and biologics-switched patients with rheumatoid arthritis: the ANSWER cohort study
Drug Survival, Safety, and Effectiveness of Biologics in Older Patients with Psoriasis: A Comparison with Younger Patients—A BioCAPTURE Registry Study
Factors associated with discontinuation of biologics in patients with inflammatory arthritis in remission: data from the BIOBADASER registry
Treatment Discontinuation in Patients with Psoriasis Treated with Biologics: A Retrospective Analysis of German Health Claims Data
Risk of Treatment Discontinuation among Patients with Psoriasis Initiated on Ustekinumab and Other Biologics in the USA
Predictors of remission in rheumatoid arthritis patients treated with biologics: a systematic review and meta-analysis
Machine learning model for identifying important clinical features for predicting remission in patients with rheumatoid arthritis treated with biologics
Evidence-Based Approach to the Discontinuation of Immunomodulators or Biologics in Inflammatory Bowel Disease
Biologics in general medicine : with 23 tables
Serious infections in patients with self-reported psoriatic arthritis from the Psoriasis Longitudinal Assessment and Registry (PSOLAR) treated with biologics
Methotrexate Discontinuation and Dose Decreases After Therapy With Tocilizumab: Results From the Corrona Rheumatoid Arthritis Registry
Factors associated with oral glucocorticoid use in patients with rheumatoid arthritis: a drug use study from a prospective national biologics registry
Drug retention of 7 biologics and tofacitinib in biologics-naïve and biologics-switched patients with rheumatoid arthritis: the ANSWER cohort study